These drugmakers are catching up to Eli Lilly and Novo Nordisk in weight loss treatments
Questions about whether Eli Lilly and Novo Nordisk can maintain their duopoly in weight loss drugs are fair game, but
Read More
Altimmune Inc
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
Drugmakers showed off data on weight loss and diabetes drugs. Also, Oracle announced the general availability of AI documentation assistant
Read More
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly’s weight loss drug dominance
Amgen, Viking Therapeutics, Altimmune, AstraZeneca, Boehringer Ingelheim and Zealand Pharma are progressing on their own treatments. Source link
Read More
Altimmune says weight loss drug minimized muscle loss in trial results, which may set it apart
The results are a sign that Altimmune can address an area of concern around weight loss drugs, which is that
Read More
Viking stock doubled Tuesday. Here’s where the next moves in the obesity space could come from
Anti-obesity drugmakers Novo Nordisk and Eli Lilly have a huge lead on their competition, but it's coming. Source link
Read More
The weight loss drug boom isn’t over yet — here’s what to expect in the year ahead
2024 will be another big year for weight loss drugs, which soared in popularity despite hefty price tags, mixed insurance
Read More
Which stocks might be disrupted next by Ozempic and other GLP-1 drugs
GLP-1 medications could have far-reaching implications for a wide variety of conditions, from liver disease to sleep apnea to heart
Read More
Here are Thursday’s biggest analyst calls: Apple, Amazon, Tesla, Chipotle, Capital One, United & more
Here are the biggest calls on Wall Street on Source link
Read More